Skip to main content

Advertisement

SpringerLink
Log in

Common genetic variation of insulin-like growth factor-binding protein 1 (IGFBP-1), IGFBP-3, and acid labile subunit in relation to serum IGF-I levels and mammographic density

  • Epidemiology
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

Mammographic density is strongly related to increased breast cancer risk. Accumulating evidence indicates that a role for the IGF-pathway in mammographic density and breast cancer development. Here, we investigate whether common genetic variation in this pathway influences insulin-like growth factor-I (IGF-I) levels and mammographic density. In 1,916 premenopausal women within the Prospect-EPIC cohort, we examined associations of 14 haplotype tagging SNPs in the ALS, IGFBP1, and IGFBP3 genes with IGF-I circulating levels and mammographic density. In 657 women, who became postmenopausal during follow-up, we investigated how these SNPs were related with the decrease in density over menopause. Linear regression models were used for statistical analysis. None of the ALS or IGFBP3 SNPs were statistically significantly associated with IGF-I levels or mammographic density. The CC genotype for rs1908751 (IGFBP1) was associated with lower levels of IGF-I (110.9 ng/ml) compared to the CT/TT genotypes (115.7 ng/ml) (P = 0.04). Women with the CC genotype also had lower percent density, although not statistically significantly (P = 0.12). Women carrying the AA genotype for rs1995051 (IGFBP1) showed that borderline significantly lower IGF-I levels (P = 0.06) and significantly lower mammographic density (40.3% compared to 43.5% in the GG/GA genotypes; P = 0.05). No relationships were found for any of the SNPs in relation with changes in breast density over menopause. These findings suggest that common genetic variation in the IGFBP1 gene is weakly related to IGF-I levels and mammographic density. Our results do not provide support for such a role of genetic variants in the IGFBP3 and ALS genes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Boyd NF, Rommens JM, Vogt K, Lee V, Hopper JL, Yaffe MJ, Paterson AD (2005) Mammographic breast density as an intermediate phenotype for breast cancer. Lancet Oncol 6:798–808

    Article  PubMed  Google Scholar 

  2. Guo YP, Martin LJ, Hanna W, Banerjee D, Miller N, Fishell E, Khokha R, Boyd NF (2001) Growth factors and stromal matrix proteins associated with mammographic densities. Cancer Epidemiol Biomarkers Prev 10:243–248

    CAS  PubMed  Google Scholar 

  3. McCormack VA, dos SS I (2006) Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev 15:1159–1169

    Article  PubMed  Google Scholar 

  4. Kleinberg DL (1998) Role of IGF-I in normal mammary development. Breast Cancer Res Treat 47:201–208

    Article  CAS  PubMed  Google Scholar 

  5. Lee AV, Yee D (1995) Insulin-like growth factors and breast cancer. Biomed Pharmacother 49:415–421

    Article  CAS  PubMed  Google Scholar 

  6. Sachdev D, Yee D (2001) The IGF system and breast cancer. Endocr Relat Cancer 8:197–209

    Article  CAS  PubMed  Google Scholar 

  7. Boyd NF, Stone J, Martin LJ, Jong R, Fishell E, Yaffe M, Hammond G, Minkin S (2002) The association of breast mitogens with mammographic densities. Br J Cancer 87:876–882

    Article  CAS  PubMed  Google Scholar 

  8. Byrne C, Colditz GA, Willett WC, Speizer FE, Pollak M, Hankinson SE (2000) Plasma insulin-like growth factor (IGF) I, IGF-binding protein 3, and mammographic density. Cancer Res 60:3744–3748

    CAS  PubMed  Google Scholar 

  9. Diorio C, Pollak M, Byrne C, Masse B, Hebert-Croteau N, Yaffe M, Cote G, Berube S, Morin C, Brisson J (2005) Insulin-like growth factor-I, IGF-binding protein-3, and mammographic breast density. Cancer Epidemiol Biomarkers Prev 14:1065–1073

    Article  CAS  PubMed  Google Scholar 

  10. Maskarinec G, Williams AE, Kaaks R (2003) A cross-sectional investigation of breast density and insulin-like growth factor I. Int J Cancer 107:991–996

    Article  CAS  PubMed  Google Scholar 

  11. dos Santos Silva I, Johnson N, De Stavola B, Torres-Mejia G, Fletcher O, Allen DS, Allen NE, Key TJ, Fentiman IS, Holly JM, Peto J (2006) The insulin-like growth factor system and mammographic features in premenopausal and postmenopausal women. Cancer Epidemiol Biomarkers Prev 15:449–455

    Article  PubMed  Google Scholar 

  12. Lai JH, Vesprini D, Zhang W, Yaffe MJ, Pollak M, Narod SA (2004) A polymorphic locus in the promoter region of the IGFBP3 gene is related to mammographic breast density. Cancer Epidemiol Biomarkers Prev 13:573–582

    CAS  PubMed  Google Scholar 

  13. Verheus M, Peeters PH, Kaaks R, Van Noord PA, Grobbee DE, Van Gils CH (2007) Premenopausal insulin-like growth factor-I serum levels and changes in breast density over menopause. Cancer Epidemiol Biomarkers Prev 16:451–457

    Article  CAS  PubMed  Google Scholar 

  14. Jones JI, Clemmons DR (1995) Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 16:3–34

    CAS  PubMed  Google Scholar 

  15. Baxter RC (1994) Insulin-like growth factor binding proteins in the human circulation: a review. Horm Res 42:140–144

    Article  CAS  PubMed  Google Scholar 

  16. Rajah R, Valentinis B, Cohen P (1997) Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-beta1 on programmed cell death through a p53- and IGF-independent mechanism. J Biol Chem 272:12181–12188

    Article  CAS  PubMed  Google Scholar 

  17. Schedlich LJ, Graham LD (2002) Role of insulin-like growth factor binding protein-3 in breast cancer cell growth. Microsc Res Tech 59:12–22

    Article  CAS  PubMed  Google Scholar 

  18. Al Zahrani A, Sandhu MS, Luben RN, Thompson D, Baynes C, Pooley KA, Luccarini C, Munday H, Perkins B, Smith P, Pharoah PD, Wareham NJ, Easton DF, Ponder BA, Dunning AM (2006) IGF1 and IGFBP3 tagging polymorphisms are associated with circulating levels of IGF1, IGFBP3 and risk of breast cancer. Hum Mol Genet 15:1–10

    Article  CAS  PubMed  Google Scholar 

  19. Canzian F, McKay JD, Cleveland RJ, Dossus L, Biessy C, Rinaldi S, Landi S, Boillot C, Monnier S, Chajes V, Clavel-Chapelon F, Tehard B, Chang-Claude J, Linseisen J, Lahmann PH, Pischon T, Trichopoulos D, Trichopoulou A, Zilis D, Palli D, Tumino R, Vineis P, Berrino F, Bueno-de-Mesquita HB, Van Gils CH, Peeters PH, Pera G, Ardanaz E, Chirlaque MD, Quiros JR, Larranaga N, Martinez-Garcia C, Allen NE, Key TJ, Bingham SA, Khaw KT, Slimani N, Norat T, Riboli E, Kaaks R (2006) Polymorphisms of genes coding for insulin-like growth factor 1 and its major binding proteins, circulating levels of IGF-I and IGFBP-3 and breast cancer risk: results from the EPIC study. Br J Cancer 94:299–307

    Article  CAS  PubMed  Google Scholar 

  20. Deal C, Ma J, Wilkin F, Paquette J, Rozen F, Ge B, Hudson T, Stampfer M, Pollak M (2001) Novel promoter polymorphism in insulin-like growth factor-binding protein-3: correlation with serum levels and interaction with known regulators. J Clin Endocrinol Metab 86:1274–1280

    Article  CAS  PubMed  Google Scholar 

  21. Ren Z, Cai Q, Shu XO, Cai H, Li C, Yu H, Gao YT, Zheng W (2004) Genetic polymorphisms in the IGFBP3 gene: association with breast cancer risk and blood IGFBP-3 protein levels among Chinese women. Cancer Epidemiol Biomarkers Prev 13:1290–1295

    CAS  PubMed  Google Scholar 

  22. Schernhammer ES, Hankinson SE, Hunter DJ, Blouin MJ, Pollak MN (2003) Polymorphic variation at the -202 locus in IGFBP3: Influence on serum levels of insulin-like growth factors, interaction with plasma retinol and vitamin D and breast cancer risk. Int J Cancer 107:60–64

    Article  CAS  PubMed  Google Scholar 

  23. Tamimi RM, Cox DG, Kraft P, Pollak MN, Haiman CA, Cheng I, Freedman ML, Hankinson SE, Hunter DJ, Colditz GA (2007) Common genetic variation in IGF1, IGFBP-1, and IGFBP-3 in relation to mammographic density: a cross-sectional study. Breast Cancer Res 9:R18

    Article  PubMed  Google Scholar 

  24. Riboli E, Kaaks R (1997) The EPIC Project: rationale and study design. European Prospective Investigation into Cancer and Nutrition. Int J Epidemiol 26(Suppl 1):S6–S14

    Article  PubMed  Google Scholar 

  25. Boker LK, Van Noord PA, van der Schouw YT, Koot NV, Bueno De Mesquita HB, Riboli E, Grobbee DE, Peeters PH (2001) Prospect-EPIC Utrecht: study design and characteristics of the cohort population. European Prospective Investigation into Cancer and Nutrition. Eur J Epidemiol 17:1047–1053

    Article  CAS  PubMed  Google Scholar 

  26. Altshuler D, Brooks LD, Chakravarti A, Collins FS, Daly MJ et al (2005) A haplotype map of the human genome. Nature 437:1299–1320

    Article  Google Scholar 

  27. Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21:263–265

    Article  CAS  PubMed  Google Scholar 

  28. Byng JW, Boyd NF, Fishell E, Jong RA, Yaffe MJ (1994) The quantitative analysis of mammographic densities. Phys Med Biol 39:1629–1638

    Article  CAS  PubMed  Google Scholar 

  29. Boyd NF, Martin LJ, Sun L, Guo H, Chiarelli A, Hislop G, Yaffe M, Minkin S (2006) Body size, mammographic density, and breast cancer risk. Cancer Epidemiol Biomarkers Prev 15:2086–2092

    Article  PubMed  Google Scholar 

  30. Renehan AG, Frystyk J, Flyvbjerg A (2006) Obesity and cancer risk: the role of the insulin-IGF axis. Trends Endocrinol Metab 17:328–336

    Article  CAS  PubMed  Google Scholar 

  31. Wacholder S, Chanock S, Garcia-Closas M, El Ghormli L, Rothman N (2004) Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst 96:434–442

    Article  PubMed  Google Scholar 

  32. Patel AV, Cheng I, Canzian F, Le ML, Thun MJ, Berg CD, Buring J, Calle EE, Chanock S, Clavel-Chapelon F, Cox DG, Dorronsoro M, Dossus L, Haiman CA, Hankinson SE, Henderson BE, Hoover R, Hunter DJ, Kaaks R, Kolonel LN, Kraft P, Linseisen J, Lund E, Manjer J, McCarty C, Peeters PH, Pike MC, Pollak M, Riboli E, Stram DO, Tjonneland A, Travis RC, Trichopoulos D, Tumino R, Yeager M, Ziegler RG, Feigelson HS (2008) IGF-1, IGFBP-1, and IGFBP-3 polymorphisms predict circulating IGF levels but not breast cancer risk: findings from the Breast and Prostate Cancer Cohort Consortium (BPC3). PLoS ONE 3:e2578

    Article  PubMed  Google Scholar 

  33. Diorio C, Brisson J, Berube S, Pollak M (2008) Genetic polymorphisms involved in insulin-like growth factor (IGF) pathway in relation to mammographic breast density and IGF levels. Cancer Epidemiol Biomarkers Prev 17:880–888

    Article  CAS  PubMed  Google Scholar 

  34. Boyd N, Martin L, Stone J, Little L, Minkin S, Yaffe M (2002) A longitudinal study of the effects of menopause on mammographic features. Cancer Epidemiol Biomarkers Prev 11:1048–1053

    PubMed  Google Scholar 

  35. Maskarinec G, Pagano I, Lurie G, Kolonel LN (2006) A longitudinal investigation of mammographic density: the multiethnic cohort. Cancer Epidemiol Biomarkers Prev 15:732–739

    Article  PubMed  Google Scholar 

  36. Vachon CM, Pankratz VS, Scott CG, Maloney SD, Ghosh K, Brandt KR, Milanese T, Carston MJ, Sellers TA (2007) Longitudinal trends in mammographic percent density and breast cancer risk. Cancer Epidemiol Biomarkers Prev 16:921–928

    Article  PubMed  Google Scholar 

  37. Kerlikowske K, Ichikawa L, Miglioretti DL, Buist DS, Vacek PM, Smith-Bindman R, Yankaskas B, Carney PA, Ballard-Barbash R (2007) Longitudinal measurement of clinical mammographic breast density to improve estimation of breast cancer risk. J Natl Cancer Inst 99:386–395

    Article  PubMed  Google Scholar 

  38. Twisk JWR (2005) Applied longitudinal data analysis for epidemiology: a practical guide. Cambridge University Press, Cambridge

    Google Scholar 

  39. van Duijnhoven FJ, Peeters PH, Warren RM, Bingham SA, Van Noord PA, Monninkhof EM, Grobbee DE, Van Gils CH (2007) Postmenopausal hormone therapy and changes in mammographic density. J Clin Oncol 25:1323–1328

    Article  PubMed  Google Scholar 

  40. Allen NE, Appleby PN, Kaaks R, Rinaldi S, Davey GK, Key TJ (2003) Lifestyle determinants of serum insulin-like growth-factor-I (IGF-I), C-peptide and hormone binding protein levels in British women. Cancer Causes Control 14:65–74

    Article  PubMed  Google Scholar 

  41. Holmes MD, Pollak MN, Hankinson SE (2002) Lifestyle correlates of plasma insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations. Cancer Epidemiol Biomarkers Prev 11:862–867

    CAS  PubMed  Google Scholar 

  42. Voskuil DW, Bueno De Mesquita HB, Kaaks R, Van Noord PA, Rinaldi S, Riboli E, Grobbee DE, Peeters PH (2001) Determinants of circulating insulin-like growth factor (IGF)-I and IGF binding proteins 1–3 in premenopausal women: physical activity and anthropometry (Netherlands). Cancer Causes Control 12:951–958

    Article  CAS  PubMed  Google Scholar 

  43. Lukanova A, Lundin E, Zeleniuch-Jacquotte A, Muti P, Mure A, Rinaldi S, Dossus L, Micheli A, Arslan A, Lenner P, Shore RE, Krogh V, Koenig KL, Riboli E, Berrino F, Hallmans G, Stattin P, Toniolo P, Kaaks R (2004) Body mass index, circulating levels of sex-steroid hormones, IGF-I and IGF-binding protein-3: a cross-sectional study in healthy women. Eur J Endocrinol 150:161–171

    Article  CAS  PubMed  Google Scholar 

  44. Baxter RC (2001) Signalling pathways involved in antiproliferative effects of IGFBP-3: a review. Mol Pathol 54:145–148

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This study was supported by Grant Number 2002/11 of the World Cancer Research Fund (WCRF).

Author information

Authors and Affiliations

  1. Julius Center for Health Sciences and Primary Care, University Medical Center, Room Str 6.131, PO Box 85500, Utrecht, 3508, GA, The Netherlands

    Cornelia W. Taverne, Martijn Verheus, Diederick E. Grobbee, Petra H. M. Peeters & Carla H. van Gils

  2. Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands

    Martijn Verheus

  3. Genetic Epidemiology Group, International Agency for Research on Cancer (IARC–WHO), Lyon, France

    James D. McKay

  4. Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany

    Rudolf Kaaks

  5. Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany

    Federico Canzian

  6. Department of Epidemiology and Public Health, Faculty of Medicine, Imperial College, London, UK

    Petra H. M. Peeters

Authors
  1. Cornelia W. Taverne
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Martijn Verheus
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. James D. McKay
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Rudolf Kaaks
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Federico Canzian
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Diederick E. Grobbee
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Petra H. M. Peeters
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Carla H. van Gils
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Carla H. van Gils.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Taverne, C.W., Verheus, M., McKay, J.D. et al. Common genetic variation of insulin-like growth factor-binding protein 1 (IGFBP-1), IGFBP-3, and acid labile subunit in relation to serum IGF-I levels and mammographic density. Breast Cancer Res Treat 123, 843–855 (2010). https://doi.org/10.1007/s10549-010-0778-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-010-0778-2

Keywords

Search

Navigation